Punit Dhillon — SPARQNOW

At-a-Glance

President & CEO at Skye Bioscience, Inc.
Two-time public biotech CEO
Raised over $700 million and led seven acquisitions
Founded OncoSec (NASDAQ: ONCS)
Co-founded YELL Canada, a high school entrepreneurship program
Achieved NYSE and Nasdaq listings for companies
Led four simultaneous deals, raising $125M for a Nasdaq-listed fibrosis company

Biography

Punit Dhillon is an experienced leader in the biotechnology sector, serving as President & CEO at Skye Bioscience, Inc. He is a two-time public biotech CEO with over twenty years of experience, during which he has raised more than $700 million, overseen seven acquisitions, and achieved NYSE and Nasdaq listings. His career includes taking two novel mechanisms into randomized Phase 2 clinical trials.